23 Jan 2024
07:00 CET |
BIOSENIC |
BioSenic files for additional patent protection following new clinical evidence of efficacy for JTA-004 in osteoarthritis
|
20103010 Biotechnology |
Corporate life |
23 Jan 2024
07:00 CET |
ION BEAM APPLICATIONS |
iThemba LABS ready to start production of Strontium-82 and Germanium-68 using IBA Cyclone® 70
|
20102010 Medical Equipment |
Other subject |
23 Jan 2024
07:00 CET |
BIOSENIC |
BioSenic dépose une demande de protection supplémentaire par brevet, suite à de nouvelles preuves cliniques de l'efficacité de JTA-004 dans le traitement de l'arthrose
|
20103010 Biotechnology |
Corporate life |
23 Jan 2024
07:00 CET |
ION BEAM APPLICATIONS |
iThemba LABS prêt à produire du strontium-82 et du germanium-68 avec un Cyclone® 70 d'IBA
|
20102010 Medical Equipment |
Other subject |
22 Jan 2024
22:02 CET |
OXURION |
Oxurion Announces New Strategic Orientation to De-risk and Diversify
|
20103010 Biotechnology |
- |
22 Jan 2024
20:03 CET |
ONWARD MEDICAL |
ONWARD® to Participate in Basel Healthtech Conference 2024
|
20101025 Health Services |
- |
22 Jan 2024
18:05 CET |
GBL |
GBL - Transacties op GBL-aandelen 22-01-2024
|
30202000 Diversified Financial Services |
Other financial transaction |
22 Jan 2024
18:04 CET |
GBL |
GBL - Transactions sur actions propres 22-01-2024
|
30202000 Diversified Financial Services |
Other financial transaction |
22 Jan 2024
18:03 CET |
GBL |
GBL - Transactions on GBL shares 22-01-2024
|
30202000 Diversified Financial Services |
Other financial transaction |
22 Jan 2024
18:00 CET |
BIOTALYS NV |
Biotalys Notice of Full Year 2023 Results and Business Highlights
|
55201015 Fertilizers |
- |
22 Jan 2024
17:45 CET |
KINEPOLIS GROUP |
Update inkoopprogramma eigen aandelen (22 januari 2024)
|
40301010 Entertainment |
Corporate life |
22 Jan 2024
17:45 CET |
KINEPOLIS GROUP |
Update share buyback program (22 January 2024)
|
40301010 Entertainment |
Corporate life |
22 Jan 2024
17:45 CET |
KINEPOLIS GROUP |
Mise à jour concernant le programme de rachat d'actions propres (22 janvier 2024)
|
40301010 Entertainment |
Corporate life |
22 Jan 2024
17:40 CET |
AGEAS |
New composition of Ageas’s Executive Committee
|
30301010 Life Insurance |
- |
22 Jan 2024
17:40 CET |
AGEAS |
Nouvelle composition de l’Executive Committee d'Ageas
|
30301010 Life Insurance |
- |
22 Jan 2024
17:40 CET |
AGEAS |
Nieuwe samenstelling van Ageas’ Executive Committee
|
30301010 Life Insurance |
- |
22 Jan 2024
15:12 CET |
KBC |
Redemption notice to the holders of the notes
|
30101010 Banks |
Other subject |
22 Jan 2024
07:22 CET |
JENSEN-GROUP |
Inkoop eigen aandelen - wekelijkse update
|
50204000 Machinery: Industrial |
Other subject |
22 Jan 2024
07:21 CET |
JENSEN-GROUP |
Share buyback – weekly update
|
50204000 Machinery: Industrial |
Other subject |
19 Jan 2024
19:00 CET |
OXURION |
Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas
|
20103010 Biotechnology |
- |
19 Jan 2024
18:48 CET |
ONWARD MEDICAL |
ONWARD® to Participate in Degroof Petercam Healthcare Conference
|
20101025 Health Services |
- |
19 Jan 2024
18:00 CET |
VASTNED BELGIUM |
Vastned Belgium: Refinancement des lignes de crédit existantes
|
35102045 Retail REITs |
Corporate life |
19 Jan 2024
18:00 CET |
VASTNED BELGIUM |
Vastned Belgium: Herfinanciering van de bestaande kredietlijnen
|
35102045 Retail REITs |
Corporate life |
19 Jan 2024
18:00 CET |
VASTNED BELGIUM |
Vastned Belgium: Refinancing of the existing credit lines
|
35102045 Retail REITs |
Corporate life |
19 Jan 2024
08:15 CET |
BEKAERT |
Bekaert - Update over het Inkoopprogramma van Eigen Aandelen
|
55102010 Iron and Steel |
Legal |
19 Jan 2024
08:15 CET |
BEKAERT |
Bekaert - Update on the Share Buyback Program
|
55102010 Iron and Steel |
Legal |
19 Jan 2024
08:15 CET |
BEKAERT |
Bekaert - Mise à jour relative au Programme de Rachat d’Actions
|
55102010 Iron and Steel |
Legal |
18 Jan 2024
19:00 CET |
HYLORIS |
Hyloris Broadens Pipeline with new Product Candidate for Vulvar Lichen Sclerosus (VLS)
|
20103010 Biotechnology |
Products and services |
18 Jan 2024
19:00 CET |
HYLORIS |
Hyloris Elargit son Portefeuille de Produits avec un Nouveau Produit Candidat pour le Lichen Scléreux Vulvaire (LSV)
|
20103010 Biotechnology |
Products and services |
18 Jan 2024
18:00 CET |
VAN DE VELDE |
VAN DE VELDE : inkoop eigen aandelen
|
40204020 Clothing and Accessories |
Other subject |
18 Jan 2024
18:00 CET |
VAN DE VELDE |
VAN DE VELDE : acquisition of treasury shares
|
40204020 Clothing and Accessories |
Other subject |
18 Jan 2024
17:52 CET |
LOTUS BAKERIES |
Disposal of treasury shares
|
45102020 Food Products |
Other subject |
18 Jan 2024
17:45 CET |
DMS IMAGING S.A. |
DMS Imaging : Chiffre d'affaires annuel 2023 : +15% à 40,5 M EUR .
|
20103010 Biotechnology |
Sales, Income |
18 Jan 2024
07:30 CET |
ONWARD MEDICAL |
ONWARD® Announces Start of HemON NL Clinical Study
|
20101025 Health Services |
- |
18 Jan 2024
07:00 CET |
ARGENX SE |
argenx Announces Approval of VYVDURA® (efgartigimod alfa and hyaluronidase-qvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis
|
20103010 Biotechnology |
Other subject |
17 Jan 2024
22:05 CET |
NYXOAH SA |
Nyxoah Annonce ses Priorités Stratégiques pour 2024
|
20102010 Medical Equipment |
Other subject |
17 Jan 2024
22:05 CET |
NYXOAH SA |
Nyxoah Announces 2024 Strategic Priorities
|
20102010 Medical Equipment |
Other subject |
17 Jan 2024
19:00 CET |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
|
20103010 Biotechnology |
- |
17 Jan 2024
18:00 CET |
INTERVEST OFF-WARE |
Intervest Offices & Warehouses NV: Persbericht – Communiqué de presse – Press release: publication of a transparency notification
|
35102030 Office REITs |
Change in Capital |
17 Jan 2024
18:00 CET |
INTERVEST OFF-WARE |
Intervest Offices & Warehouses NV: Press release – Persbericht – Communiqué de presse: publication of a transparency notification
|
35102030 Office REITs |
Change in Capital |
17 Jan 2024
18:00 CET |
INTERVEST OFF-WARE |
Intervest Offices & Warehouses SA: Communiqué de presse – Persbericht - Press release: publication of a transparency notification
|
35102030 Office REITs |
Change in Capital |
17 Jan 2024
07:30 CET |
INTERVEST OFF-WARE |
Intervest Offices & Warehouses SA: Communiqué de presse – Persbericht - Press release: announcement of publication of prospectus and response memorandum regarding voluntary and conditional takeover offer in cash by TPG
|
35102030 Office REITs |
Takeover bids |
17 Jan 2024
07:30 CET |
INTERVEST OFF-WARE |
Intervest Offices & Warehouses NV: Persbericht – Communiqué de presse – Press release: announcement of publication of prospectus and response memorandum regarding voluntary and conditional takeover offer in cash by TPG
|
35102030 Office REITs |
Takeover bids |
17 Jan 2024
07:30 CET |
INTERVEST OFF-WARE |
Intervest Offices & Warehouses NV: Press release – Persbericht – Communiqué de presse: announcement of publication of prospectus and response memorandum regarding voluntary and conditional takeover offer in cash by TPG
|
35102030 Office REITs |
Takeover bids |
16 Jan 2024
22:01 CET |
CELYAD ONCOLOGY |
Celyad Oncology Provides Fourth Quarter 2023 Business Update and 2024 Outlook
|
20103010 Biotechnology |
Corporate life |
16 Jan 2024
22:01 CET |
CELYAD ONCOLOGY |
Celyad Oncology fait le point sur les activités du quatrième trimestre 2023 et présente ses perspectives pour 2024
|
20103010 Biotechnology |
Corporate life |
16 Jan 2024
19:30 CET |
HYLORIS |
Orphan Drug Designation Granted to PTX-252 by U.S. FDA for the Treatment of Acute Myeloid Leukaemia (AML)
|
20103010 Biotechnology |
Products and services |
16 Jan 2024
19:30 CET |
HYLORIS |
La FDA Américaine Accorde la Qualification de Médicament Orphelin au PTX-252 pour le Traitement de la Leucémie Myéloïde Aiguë (LMA)
|
20103010 Biotechnology |
Products and services |
16 Jan 2024
18:00 CET |
INTERVEST OFF-WARE |
Intervest Offices & Warehouses SA: Communiqué de presse – Persbericht - Press release: publication of a transparency notification
|
35102030 Office REITs |
Change in Capital |
16 Jan 2024
18:00 CET |
INTERVEST OFF-WARE |
Intervest Offices & Warehouses NV: Persbericht – Communiqué de presse – Press release: publication of a transparency notification
|
35102030 Office REITs |
Change in Capital |